Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
April 26, 2018
Bunyavirus Taxonomy: Limitations and Misconceptions Associated with the Current ICTV Criteria Used for Species Demarcation
Bradley J Blitvich, Barry J Beaty, Carol D Blair, et al.
Vaccine
|
August 10, 2025
Community willingness to participate in a Nipah vaccine trial in Bangladesh
Nazmun Nahar, Shahana Parveen, Emily S Gurley, et al.
Emerging Microbes & Infections
|
March 15, 2021
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
Igor Morozov, Thomas P Monath, David A Meekins, et al.
Microbiology Spectrum
|
March 21, 2024
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil
Andreza Parreiras Gonçalves, Letícia Trindade Almeida, Izabela Maurício de Rezende, et al.
Free Radical Biology & Medicine
|
January 26, 2024
Yellow fever virus infection in human hepatocyte cells triggers an imbalance in redox homeostasis with increased reactive oxygen species production, oxidative stress, and decreased antioxidant enzymes
Ariane Coelho Ferraz, Marília Bueno da Silva Menegatto, Rafaela Lameira Souza Lima, et al.
The Lancet. Microbe
|
May 11, 2022
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
Eleonora Vianello, Patricia Gonzalez-Dias, Suzanne van Veen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
May S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Lancet (London, England)
|
January 10, 2021
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
Aitana Juan-Giner, Derick Kimathi, Kyra H Grantz, et al.
Viruses
|
October 29, 2025
In Vivo Characterization and Tissue Tropism of a Wild-Type Yellow Fever Virus Isolate from the 2017-2018 Brazilian Outbreak in C57BL/6 IFNAR1<sup>-/-</sup> Mice
Ana Luiza Campos Cruz, Natália Lima Pessoa, Ester Maria Paiva Silva, et al.
Open Forum Infectious Diseases
|
June 27, 2024
Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study
Izabela M Rezende, Diogo Correa Mendonça, Thais Alkifeles Costa, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
The American Journal of Tropical Medicine and Hygiene
|
April 26, 2018
Bunyavirus Taxonomy: Limitations and Misconceptions Associated with the Current ICTV Criteria Used for Species Demarcation
Bradley J Blitvich, Barry J Beaty, Carol D Blair, et al.
Vaccine
|
August 10, 2025
Community willingness to participate in a Nipah vaccine trial in Bangladesh
Nazmun Nahar, Shahana Parveen, Emily S Gurley, et al.
Emerging Microbes & Infections
|
March 15, 2021
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
Igor Morozov, Thomas P Monath, David A Meekins, et al.
Microbiology Spectrum
|
March 21, 2024
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil
Andreza Parreiras Gonçalves, Letícia Trindade Almeida, Izabela Maurício de Rezende, et al.
Free Radical Biology & Medicine
|
January 26, 2024
Yellow fever virus infection in human hepatocyte cells triggers an imbalance in redox homeostasis with increased reactive oxygen species production, oxidative stress, and decreased antioxidant enzymes
Ariane Coelho Ferraz, Marília Bueno da Silva Menegatto, Rafaela Lameira Souza Lima, et al.
The Lancet. Microbe
|
May 11, 2022
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
Eleonora Vianello, Patricia Gonzalez-Dias, Suzanne van Veen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
May S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Lancet (London, England)
|
January 10, 2021
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
Aitana Juan-Giner, Derick Kimathi, Kyra H Grantz, et al.
Viruses
|
October 29, 2025
In Vivo Characterization and Tissue Tropism of a Wild-Type Yellow Fever Virus Isolate from the 2017-2018 Brazilian Outbreak in C57BL/6 IFNAR1<sup>-/-</sup> Mice
Ana Luiza Campos Cruz, Natália Lima Pessoa, Ester Maria Paiva Silva, et al.
Open Forum Infectious Diseases
|
June 27, 2024
Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study
Izabela M Rezende, Diogo Correa Mendonça, Thais Alkifeles Costa, et al.
Page
of 14